J.E. Sedano-Basilio, E. Mayorga-Gómez, G. Garza-Sainz, V. Cornejo-Dávila, I. Uberetagoyena-Tello de Meneses, A.M. Palmeros-Rodríguez, L. Trujillo-Ortiz, J. Gómez-Sánchez, J.A. Herrera-Muñoz, D.A. Preciado-Estrella, M. Cantellano-Orozco, C. Martínez-Arroyo, J.G. Morales-Montor, C. Pacheco-Gahbler
{"title":"十年来泌尿生殖肿瘤的流行病学","authors":"J.E. Sedano-Basilio, E. Mayorga-Gómez, G. Garza-Sainz, V. Cornejo-Dávila, I. Uberetagoyena-Tello de Meneses, A.M. Palmeros-Rodríguez, L. Trujillo-Ortiz, J. Gómez-Sánchez, J.A. Herrera-Muñoz, D.A. Preciado-Estrella, M. Cantellano-Orozco, C. Martínez-Arroyo, J.G. Morales-Montor, C. Pacheco-Gahbler","doi":"10.1016/j.uromx.2016.01.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>There are no reliable epidemiologic registers of cancer in Mexico. Genitourinary cancer represents 20% of all cancers. In 2012, prostate cancer represented 21.4% of all cancers, kidney cancer 2.13%, bladder cancer 2.2%, and testicular cancer 2.7%. An epidemiologic register carried out in 2011 reported a lower incidence than that described in the international literature.</p></div><div><h3>Aim</h3><p>To know the number of new cases of the different tumors affecting the genitourinary tract.</p></div><div><h3>Material and methods</h3><p>An analytic, retrospective study was conducted, carrying out a review of the medical records with genitourinary cancer diagnoses within the time frame of January 2004 and June 2014 obtained from the Department of Histology of this institution.</p></div><div><h3>Results</h3><p>We found a total of 861 cases. Prostate cancer represented 43.4% of the total (12-56.4%/year), cancer of the penis 5.6% (2.2-11.4%/year), kidney cancer 15.3% (11-24%/year), cancer of the upper urinary tract 1.27% (0.1-0.34%/year), bladder cancer 13% (2-22.7%/year), and testicular cancer 21.2% (13.2-56.2%/year).</p></div><div><h3>Discussion</h3><p>The results of our review are consistent with those reported in the international literature. The epidemiology of cancer in Mexico is underestimated due to the lack of reliable registers.</p></div><div><h3>Conclusions</h3><p>In our case series we observed an increase in the detection of new cases of genitourinary tumors. Increased knowledge in relation to the epidemiology of genitourinary cancer in Mexico is necessary so that the resources for treating these neoplasias can be optimized.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.01.004","citationCount":"3","resultStr":"{\"title\":\"Epidemiología de los tumores genitourinarios en una década\",\"authors\":\"J.E. Sedano-Basilio, E. Mayorga-Gómez, G. Garza-Sainz, V. Cornejo-Dávila, I. Uberetagoyena-Tello de Meneses, A.M. Palmeros-Rodríguez, L. Trujillo-Ortiz, J. Gómez-Sánchez, J.A. Herrera-Muñoz, D.A. Preciado-Estrella, M. Cantellano-Orozco, C. Martínez-Arroyo, J.G. Morales-Montor, C. Pacheco-Gahbler\",\"doi\":\"10.1016/j.uromx.2016.01.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>There are no reliable epidemiologic registers of cancer in Mexico. Genitourinary cancer represents 20% of all cancers. In 2012, prostate cancer represented 21.4% of all cancers, kidney cancer 2.13%, bladder cancer 2.2%, and testicular cancer 2.7%. An epidemiologic register carried out in 2011 reported a lower incidence than that described in the international literature.</p></div><div><h3>Aim</h3><p>To know the number of new cases of the different tumors affecting the genitourinary tract.</p></div><div><h3>Material and methods</h3><p>An analytic, retrospective study was conducted, carrying out a review of the medical records with genitourinary cancer diagnoses within the time frame of January 2004 and June 2014 obtained from the Department of Histology of this institution.</p></div><div><h3>Results</h3><p>We found a total of 861 cases. Prostate cancer represented 43.4% of the total (12-56.4%/year), cancer of the penis 5.6% (2.2-11.4%/year), kidney cancer 15.3% (11-24%/year), cancer of the upper urinary tract 1.27% (0.1-0.34%/year), bladder cancer 13% (2-22.7%/year), and testicular cancer 21.2% (13.2-56.2%/year).</p></div><div><h3>Discussion</h3><p>The results of our review are consistent with those reported in the international literature. The epidemiology of cancer in Mexico is underestimated due to the lack of reliable registers.</p></div><div><h3>Conclusions</h3><p>In our case series we observed an increase in the detection of new cases of genitourinary tumors. Increased knowledge in relation to the epidemiology of genitourinary cancer in Mexico is necessary so that the resources for treating these neoplasias can be optimized.</p></div>\",\"PeriodicalId\":34909,\"journal\":{\"name\":\"Revista mexicana de urologia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.uromx.2016.01.004\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista mexicana de urologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S200740851600015X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista mexicana de urologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S200740851600015X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Epidemiología de los tumores genitourinarios en una década
Background
There are no reliable epidemiologic registers of cancer in Mexico. Genitourinary cancer represents 20% of all cancers. In 2012, prostate cancer represented 21.4% of all cancers, kidney cancer 2.13%, bladder cancer 2.2%, and testicular cancer 2.7%. An epidemiologic register carried out in 2011 reported a lower incidence than that described in the international literature.
Aim
To know the number of new cases of the different tumors affecting the genitourinary tract.
Material and methods
An analytic, retrospective study was conducted, carrying out a review of the medical records with genitourinary cancer diagnoses within the time frame of January 2004 and June 2014 obtained from the Department of Histology of this institution.
Results
We found a total of 861 cases. Prostate cancer represented 43.4% of the total (12-56.4%/year), cancer of the penis 5.6% (2.2-11.4%/year), kidney cancer 15.3% (11-24%/year), cancer of the upper urinary tract 1.27% (0.1-0.34%/year), bladder cancer 13% (2-22.7%/year), and testicular cancer 21.2% (13.2-56.2%/year).
Discussion
The results of our review are consistent with those reported in the international literature. The epidemiology of cancer in Mexico is underestimated due to the lack of reliable registers.
Conclusions
In our case series we observed an increase in the detection of new cases of genitourinary tumors. Increased knowledge in relation to the epidemiology of genitourinary cancer in Mexico is necessary so that the resources for treating these neoplasias can be optimized.
期刊介绍:
Revista Mexicana de Urología (RMU) [Mexican Journal of Urology] (ISSN: 0185-4542 / ISSN electronic: 2007-4085) is bimonthly publication that disseminates research by academicians and professionals of the international medical community interested in urological subjects, in the format of original articles, clinical cases, review articles brief communications and letters to the editor. Owing to its nature, it is publication with international scope that disseminates contributions in Spanish and English that are rigorously reviewed by peers under the double blind modality. Neither journalistic documents nor those that lack rigorous medical or scientific support are suitable for publication.